Oxidative Stress Markers in Athletes: What Your Blood Work Is Actually Telling You
Table of Contents
Key Takeaways: Oxidative Stress Markers in Athletes
- Oxidative stress markers in athletes are biologically interesting, but they are not routine clinical blood tests.
- Reactive oxygen species are not purely harmful. They also play a role in cellular signaling and training adaptation.
- The goal is not to eliminate oxidative stress completely, but to understand when it reflects normal adaptation and when it may suggest poor recovery or excessive training load.
- MDA, GSH/GSSG, protein carbonyls, urinary isoprostanes, SOD, GPx, and catalase measure oxidative stress from different angles.
- These markers should be interpreted in context, not as isolated “good” or “bad” numbers.
- Athletes may show different oxidative stress patterns than sedentary people, but this does not yet translate into clear athlete-specific clinical reference ranges.
- Overtraining syndrome remains largely a clinical diagnosis based on symptoms, training history, recovery, performance changes, and exclusion of other medical causes.
- Oxidative stress markers are not validated diagnostic tests for overtraining.
- Sampling timing matters. Recent exercise can strongly affect oxidative stress markers, making single measurements easy to misinterpret.
- Commercial wellness or biohacking panels may include oxidative stress markers, but “measurable” does not automatically mean clinically useful.
- High-dose vitamin C and E supplementation may blunt some cellular training-adaptation signals, even if clear performance reductions are not necessarily seen.
- For most athletes, the practical foundation remains simple: adequate energy intake, a varied diet, enough recovery, sensible training load, and avoiding unnecessary high-dose antioxidant supplementation without a clear individual reason.
Introduction: Oxidative Stress Markers in Athletes
Antioxidants are surrounded by a lot of noise. In marketing and popular media, they are often presented as something almost universally beneficial, while free radicals and oxidative stress are framed as purely harmful. From a medical perspective, that is too simple. Excessive oxidative stress can certainly be harmful, but reactive oxygen species are not only damaging byproducts.
According to a 2026 structured narrative review, exercise-derived reactive oxygen species (ROS) play an important role in mitochondrial and hypertrophic adaptations, creating a practical trade-off — antioxidant strategies may support short-term performance and recovery yet blunt training signals when mis-timed or over-dosed [1].
In practice, however, antioxidants remain a fairly abstract concept in everyday clinical medicine. In primary care, we do not usually measure “antioxidant status” as part of routine blood work, and there is no widely used clinical test that gives a simple, actionable answer for most patients. Even when oxidative stress is biologically interesting, it rarely leads directly to a specific treatment decision in ordinary clinical practice. Outside certain uncommon metabolic or medical conditions, antioxidant measurements are not usually something that guides day-to-day patient care.
This gap between biology and clinical usefulness is important. It may also help explain why antioxidants are so easy to market. When a concept sounds scientific but is difficult to measure clearly, it becomes easier to attach broad promises to it. In my clinical view, the practical question is not whether antioxidants are “good” or “bad,” but whether measuring them or supplementing them actually changes what we do for the patient or athlete in front of us.
In this article I will explain the primary oxidative stress markers in athletes — malondialdehyde (MDA), glutathione ratio (GSH/GSSG), protein carbonyls, urinary isoprostanes, and antioxidant enzyme activity (SOD, GPx, catalase) — what they mean in the context of sport, and how to use them when making decisions about training, recovery, and supplementation.
Why Standard Reference Ranges Deserve Scrutiny in Athletes
Published P-MDA reference limits have been derived from general-population samples. The estimated reference limits (0.025 and 0.975 fractiles) for plasma malondialdehyde (P-MDA) in a general population of 213 individuals (ages 20–79 years) were 0.36 and 1.24 μmol/L [2]. These limits should be interpreted cautiously in athletes, because training status, sport type, and recent exercise can all affect oxidative stress markers.
Group-level differences in elite populations are striking. A study screening serum samples from 88 consented elite male athletes across five sport disciplines found that SOD (p=0.001) and MDA (p=0.007) levels were greater in the higher power groups compared with the lower power counterpart [3].
Similarly, the same challenge applies across athletic blood work. Creatine kinase elevation in athletes and myoglobin follow the same pattern: markers that look alarming in sedentary patients often represent normal adaptive physiology in trained individuals.
From the perspective of everyday clinical work, however, this remains mostly a scientific and practical curiosity. Oxidative stress markers are not commonly measured in ordinary patient care, except perhaps in selected rare metabolic or specialist-level contexts. In primary care, we generally do not measure antioxidant levels as part of routine assessment, and the results would rarely lead directly to a specific treatment decision.
This also matters when discussing athlete-specific reference ranges. Even if athletes may show different patterns in oxidative stress or antioxidant-related markers, those differences do not yet translate into clear clinical action in most routine settings. In my view, this is one reason why athlete-specific reference ranges for these markers have not really developed into everyday clinical tools. At this stage, the idea is interesting from a physiology and sports science perspective, but still limited in practical clinical usefulness.
The Key Oxidative Stress Markers in Athletes Explained
The following markers are oxidative stress markers that have been studied in relation to exercise and athletic training. In simple terms, they look at oxidative stress from different angles: lipid peroxidation, redox balance, protein oxidation, systemic oxidative burden, and endogenous antioxidant enzyme activity.
From a clinical perspective, it is important to keep this in proportion. These markers are useful for understanding exercise physiology, training adaptation, and overreaching research, but they are not commonly used in everyday clinical decision-making. In primary care, there are relatively few situations where measuring these values would be clearly indicated, and for most patients they are not part of routine assessment.
Some commercial laboratory panels may include oxidative stress or antioxidant-related markers, especially in wellness, longevity, or biohacking contexts. In my view, this is where the distinction between “measurable” and “clinically useful” becomes important. A value can be biologically interesting without changing diagnosis, treatment, or follow-up in a meaningful way. For most routine clinical situations, these markers very rarely influence practical decision-making.
This is also how I would frame them when discussing athletes. The findings from exercise studies can be intellectually and physiologically interesting, but they should not be confused with standard clinical tools like ferritin, CRP, blood count, or thyroid tests. Many physicians are not especially familiar with these markers in routine practice, partly because they are rarely needed outside specific research, specialist, or unusual metabolic contexts.
Malondialdehyde (MDA) — The Primary Lipid Peroxidation Marker
MDA is one of the most frequently used indicators of lipid peroxidation [2]. In Nielsen et al., plasma MDA was measured in EDTA-treated plasma after derivatization by thiobarbituric acid (TBA) and separation on HPLC.
A systematic review of 18 studies confirmed that exercise can increase oxidative damage in an exercise type and intensity manner [4]. This is illustrated by a study in 17 trained male runners (mean peak VO₂ 63.2 ± 4.8 mL·kg⁻¹·min⁻¹) completing a simulated half-marathon, plasma MDA elevated from 1.48 ± 0.39 to 1.65 ± 0.32 mmol·L⁻¹ after exercise (P <0.05) [5] — consistent with the exercise-induced response observed in that protocol.
GSH/GSSG Ratio — The Redox Status Indicator
Reduced glutathione (GSH) and oxidized glutathione (GSSG) are key components of the intracellular redox system. In one aerobic-exercise protocol, the change in GSH/GSSG was −74 ± 9% after exercise, while TBARS increased by +129 ± 29%, protein carbonyls by +135 ± 53%, and total antioxidant capacity by +24 ± 10% [6]. The time to lowest GSH/GSSG concentration after exercise was 1.7 ± 0.7 h (mean ± SD) [6]. For reliable resting assessment, sampling timing and fasting status should be standardized.
In a non-athlete training and rehabilitation population, Elokda and Nielsen reported that aerobic exercise training (AET), circuit weight training (CWT), and combined training (AET+CWT) showed significant pre-training–post-training increases in resting GSH and the GSH:GSSG ratio, and significant decreases in GSSG levels (P<0.005), with the GSH:GSSG ratio identified as the most sensitive change marker [7].
Protein Carbonyls — Marker of Protein Oxidation
Protein carbonyls are markers of oxidative damage to proteins. After acute exercise, protein carbonyls peaked at 4.4 ± 0.5 h with a maximum change of +135 ± 53% [6]. This indicates that immediate post-exercise sampling substantially misses the peak value. In the context of overtraining, protein carbonyls rose by 73% during the highest training volume period (T3: 14 tones/week) of a 12-week resistance training protocol in 12 males [8].
Urinary Isoprostanes — A Robust Lipid Peroxidation Marker
F2-isoprostanes are regarded as relatively robust lipid peroxidation markers compared with less specific assays such as TBARS [11]. In the same 12-week overtraining protocol, overtraining induced an increase of urinary isoprostanes of 7-fold — larger than the percentage changes reported for TBARS, protein carbonyls, catalase, GSH, GSSG, GSH/GSSG, and TAC [8]. Furthermore, isoprostanes and GSH/GSSG were highly correlated with performance drop and training volume increase (r=0.764–0.911) [8].
SOD and GPx — Endogenous Antioxidant Enzyme Activity
SOD and GPx are enzymatic antioxidants. Training status can modify oxidative damage and antioxidant-status markers: the untrained group depicted more severe oxidative damage (protein carbonyls, malondialdehyde) and weaker antioxidant status (reduced glutathione, static and capacity oxidation-reduction potential) compared with trained participants after eccentric exercise [9]. In one elite-athlete cohort, SOD levels were higher (p=0.001) in high and moderate cardiovascular demand groups than in the low counterpart [3].
Oxidative Stress Markers and Overtraining Monitoring
One potential application of oxidative stress markers in athletes is monitoring responses during periods of intensified training or suspected overreaching.
In a 12-week resistance training protocol (T1: 2 tons/week, T2: 8 tons/week, T3: 14 tons/week, T4: 2 tons/week), performance (strength, power, and jumping ability) increased after T2 but declined thereafter, consistent with an overtraining response [8]. During the highest training volume period (T3), overtraining induced a marked increase in oxidative stress biomarkers, including a 7-fold rise in urinary isoprostanes, +56% in TBARS, +73% in protein carbonyls, −56% in GSH/GSSG ratio, and a reduction in total antioxidant capacity [8]. Isoprostanes and GSH/GSSG showed strong correlations with performance decline and training volume (r = 0.764–0.911) [8].
These findings suggest that oxidative stress markers may provide useful additional information as part of a broader overtraining monitoring approach, although no single marker is diagnostic.
It is important to keep overtraining syndrome in the right clinical frame. In everyday medical practice, overtraining is still largely a clinical diagnosis. Laboratory tests are usually used to rule out other medical explanations for fatigue, poor recovery, reduced performance, sleep disturbance, mood changes, or other symptoms that may overlap with overtraining.
In a very high-resource sports setting, some athletes may have regular baseline data available, including blood work, HRV, performance metrics, sleep data, and other physiological measurements. In that situation, changes in oxidative stress markers might add one more piece of context. But even then, these values need to be interpreted together with the athlete’s symptoms, training history, recovery status, and other available data. They are not a standalone diagnostic tool.
In my clinical experience, the situation is usually different. By the time someone presents to a doctor with possible overtraining, there is often no long-term baseline data available. At that point, laboratory testing is mainly useful for excluding other conditions rather than proving overtraining directly. The diagnosis then depends heavily on the clinical history, the pattern of training load and recovery, symptom development, and the exclusion of relevant comorbidities or alternative diagnoses.
These markers work best alongside a broader panel. Cortisol and overtraining, the testosterone-to-cortisol ratio, and HRV and blood work each capture different dimensions of the same physiological picture. In some athletes, oxidative stress markers may add information when symptoms, HRV, CK, and hormonal markers do not provide a clear answer — but this remains a clinical interpretation, not a validated diagnostic rule.
This is why oxidative stress markers, although scientifically interesting, should not be presented as definitive clinical tests for overtraining. They may change in overtraining research, but that does not automatically make them part of standard clinical decision-making. In practice, patients and athletes may spend significant money on these measurements without getting results that clearly change diagnosis, treatment, or follow-up. At least in routine clinical work, and especially in primary care, these markers remain an interesting adjunct rather than a guideline-based diagnostic tool.
The Antioxidant Supplementation Paradox
High-dose vitamin C/E supplementation can blunt some cellular markers of endurance training adaptation — although performance outcomes may not be detectably affected. Exercise-derived ROS participate in signaling pathways that drive adaptation, and high-dose antioxidants can interfere with these [1].
In a double-blind RCT, 54 young healthy men and women received either 1000 mg vitamin C and 235 mg vitamin E daily or placebo for 11 weeks of endurance training. Vitamin C and E supplements blunted the endurance training-induced increase of mitochondrial proteins (COX4), which is important for improving muscular endurance, and the authors concluded that high dosages of vitamins C and E should be used with caution [10].
For the evidence on individual compounds, see CoQ10 in Athletes, Omega-3 for Athletes, Vitamin E in Athletes, and Vitamin A in Athletes. Vitamins for Athletes covers the full evidence base.
In practical clinical work, especially in a country like Finland, my experience is that clinically meaningful vitamin C or vitamin E deficiency is not something I would automatically suspect in an otherwise healthy athlete who eats a varied mixed diet. That does not mean nutrition is irrelevant, and individual situations can differ, but performance problems are rarely explained by antioxidant vitamin status alone without a broader dietary or medical context.
Vitamin C is often treated by the public as a harmless supplement, partly because it is water-soluble and widely marketed. Vitamin E is usually approached with more caution, because it is fat-soluble and excessive intake is not something to pursue casually. Based on my clinical experience, I would not frame extra vitamin C or vitamin E supplementation as a default requirement for athletes who already eat reasonably well.
This becomes especially relevant when discussing adaptation. As discussed above, high-dose vitamin C and E supplementation may blunt some cellular signals related to training adaptation, even if clear reductions in objective performance have not necessarily been shown. In practice, my experience is that the foundation is usually simpler: adequate energy intake, a varied diet, and avoiding unnecessary high-dose antioxidant supplementation unless there is a clear individual reason to consider it.
If an athlete chooses to use a supplement anyway, context matters. The goal is not to suppress every oxidative signal, because some oxidative stress is part of normal training physiology. Low-dose general supplement use is different from aggressive high-dose antioxidant use, and that distinction matters when thinking about both safety and adaptation.
Conclusion: Oxidative Stress Markers in Athletes
Oxidative stress markers in athletes are best understood as context markers, not standalone answers. They can tell us something about how the body is responding to training stress, but they do not replace clinical judgment, training history, symptom assessment, or more established blood tests. Exercise-related reactive oxygen species are not simply harmful waste products. They are also part of the signaling environment that helps the body adapt to training. This is why the goal should not be to eliminate oxidative stress completely, but to understand when it may reflect a normal training response and when it may suggest that recovery, nutrition, illness, or training load deserve closer attention.
Markers such as MDA, GSH/GSSG, protein carbonyls, urinary isoprostanes, SOD, GPx, and catalase can be useful for understanding exercise physiology and overreaching research. In high-resource sport settings, especially when repeated baseline measurements are available, they may add another layer to the overall picture. However, in routine clinical practice, and especially in primary care, these markers are rarely measured and rarely lead directly to a specific treatment decision. That distinction matters. A marker can be biologically interesting without being clinically actionable.
This is especially important in the context of overtraining. Overtraining syndrome remains largely a clinical diagnosis. Laboratory tests are usually used to rule out other medical explanations for fatigue, poor recovery, declining performance, sleep disturbance, mood changes, or other overlapping symptoms. Oxidative stress markers may change during overreaching or overtraining research protocols, but they should not be presented as definitive diagnostic tests. They are not a validated shortcut to diagnosing overtraining, and they should not be used in isolation to decide whether an athlete is adapting well or breaking down.
The same balanced thinking applies to antioxidants. It is easy to assume that if oxidative stress is involved, more antioxidants must be better. The physiology is more complicated. High-dose vitamin C and E supplementation may blunt some cellular signals involved in training adaptation, even if clear performance reductions are not consistently shown. From a practical clinical perspective, the foundation is usually simpler: adequate energy intake, a varied diet, enough recovery, and avoiding unnecessary high-dose antioxidant supplementation unless there is a clear individual reason to consider it.
In my view, the real value of oxidative stress markers is not that they give athletes another number to chase. Their value is in helping explain why training adaptation, fatigue, recovery, and supplementation cannot be reduced to a simple “oxidants bad, antioxidants good” model. For most athletes, the most useful takeaway is not to order every possible oxidative stress panel, but to interpret the basics well: training load, sleep, nutrition, symptoms, performance trends, and conventional blood work. Oxidative stress markers may add context in selected cases, but they remain an adjunct — not a replacement for careful clinical reasoning.
Bibliography
[1] https://www.mdpi.com/2076-3921/15/4/456
[2] https://pubmed.ncbi.nlm.nih.gov/9216458/
[3] https://doi.org/10.3389/fphys.2020.600888
[4] https://doi.org/10.1155/2021/1947928
[5] https://pubmed.ncbi.nlm.nih.gov/9813873/
[6] https://pubmed.ncbi.nlm.nih.gov/17596778/
[7] https://pubmed.ncbi.nlm.nih.gov/17925621/
[8] https://pubmed.ncbi.nlm.nih.gov/17697935/
[9] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079342/
